{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:39Z","timestamp":1786985439797,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"NIDCR","doi-asserted-by":"publisher","award":["R15DE025134"],"award-info":[{"award-number":["R15DE025134"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","award":["2P01AG036675-06A1"],"award-info":[{"award-number":["2P01AG036675-06A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.bone.2018.01.030","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T03:56:35Z","timestamp":1518148595000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function"],"prefix":"10.1016","volume":"110","author":[{"given":"Ranya","family":"Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pheba","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Kurago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasudha","family":"Baladhandayutham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Whitford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Pashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-8217","authenticated-orcid":false,"given":"Mohammed E.","family":"Elsalanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2018.01.030_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bone.2018.01.030_bb0010","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/ijc.24470","article-title":"The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis","volume":"125","author":"Zarogoulidis","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bone.2018.01.030_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jbo.2015.08.001","article-title":"Dosing of zoledronic acid with its anti-tumor effects in breast cancer","volume":"4","author":"Zhao","year":"2015","journal-title":"J. Bone Oncol."},{"issue":"10001","key":"10.1016\/j.bone.2018.01.030_bb0020","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative G","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bone.2018.01.030_bb0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.pcan.4500607","article-title":"The potential role of bisphosphonates in prostate cancer","volume":"5","author":"Oades","year":"2002","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"9","key":"10.1016\/j.bone.2018.01.030_bb0030","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1470-2045(14)70302-X","article-title":"Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01\/04) randomised open-label phase 3 trial","volume":"15","author":"Coleman","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bone.2018.01.030_bb0035","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ctrv.2008.03.006","article-title":"Antitumor effects of bisphosphonates: promising preclinical evidence","volume":"34","author":"Guise","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.bone.2018.01.030_bb0040","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.bbagen.2013.01.020","article-title":"Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease","volume":"1830","author":"Dedes","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"12","key":"10.1016\/j.bone.2018.01.030_bb0045","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/0008-5472.CAN-05-0264","article-title":"Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity","volume":"65","author":"Clezardin","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bone.2018.01.030_bb0050","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"8","key":"10.1016\/j.bone.2018.01.030_bb0055","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jbmr.2832","article-title":"Impact of the U.S. food and drug administration's safety-related announcements on the use of bisphosphonates after hip fracture","volume":"31","author":"Kim","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2018.01.030_bb0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the Jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"2","key":"10.1016\/j.bone.2018.01.030_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2011.181","article-title":"Epidemiology and pathogenesis of osteonecrosis of the jaw","volume":"8","author":"Reid","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.bone.2018.01.030_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1185\/03007995.2015.1016605","article-title":"Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy","volume":"31","author":"Modi","year":"2015","journal-title":"Curr. Med. Res. Opin."},{"issue":"12","key":"10.1016\/j.bone.2018.01.030_bb0075","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.archoralbio.2015.09.001","article-title":"Removal of pamidronate from bone in rats using systemic and local chelation","volume":"60","author":"Howie","year":"2015","journal-title":"Arch. Oral Biol."},{"issue":"10","key":"10.1016\/j.bone.2018.01.030_bb0080","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1124\/dmd.108.021071","article-title":"Biodistribution and plasma protein binding of zoledronic acid","volume":"36","author":"Weiss","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bone.2018.01.030_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/bonekey.2014.24","article-title":"Bisphosphonates and bone quality","volume":"3","author":"Pazianas","year":"2014","journal-title":"BoneKEy Rep."},{"issue":"4","key":"10.1016\/j.bone.2018.01.030_bb0090","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jbmr.1543","article-title":"Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo","volume":"27","author":"Roelofs","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2018.01.030_bb0095","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.bone.2018.01.030_bb0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","article-title":"Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite","volume":"38","author":"Nancollas","year":"2006","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2018.01.030_bb0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bone.2018.01.030_bb0110","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jbmr.66","article-title":"Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo","volume":"25","author":"Kozloff","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2018.01.030_bb0115","first-page":"S135","article-title":"Ethylenediaminetetraacetic acid in endodontics","volume":"7","author":"Mohammadi","year":"2013","journal-title":"Eur. J. Dent. Educ."},{"issue":"4","key":"10.1016\/j.bone.2018.01.030_bb0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13181-013-0343-6","article-title":"The role of chelation in the treatment of other metal poisonings","volume":"9","author":"Smith","year":"2013","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.bone.2018.01.030_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/15376516.2012.730562","article-title":"EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk\/benefit assessment","volume":"23","author":"Born","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"issue":"11","key":"10.1016\/j.bone.2018.01.030_bb0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11886-015-0656-y","article-title":"EDTA chelation therapy to reduce cardiovascular events in persons with diabetes","volume":"17","author":"Ouyang","year":"2015","journal-title":"Curr. Cardiol. Rep."},{"issue":"3","key":"10.1016\/j.bone.2018.01.030_bb0135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.joen.2011.11.013","article-title":"Comparison of the effect of four decalcifying agents combined with 60 degrees C 3% sodium hypochlorite on smear layer removal","volume":"38","author":"Wu","year":"2012","journal-title":"J. Endod."},{"issue":"1","key":"10.1016\/j.bone.2018.01.030_bb0140","first-page":"11","article-title":"The effects of EDTA gel conditioning exposure time on periodontitis-affected human root surfaces: surface topography and PDL cell adhesion","volume":"5","author":"Gamal","year":"2003","journal-title":"J. Int. Acad. Periodontol."},{"issue":"7","key":"10.1016\/j.bone.2018.01.030_bb0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00004770-200207000-00002","article-title":"The demineralizing effects of EDTA at different concentrations and pH","volume":"28","author":"Serper","year":"2002","journal-title":"J. Endod."},{"issue":"8","key":"10.1016\/j.bone.2018.01.030_bb0150","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1177\/00220345870660081801","article-title":"In vitro infection and disinfection of dentinal tubules","volume":"66","author":"Haapasalo","year":"1987","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bone.2018.01.030_bb0155","article-title":"Effect of low-surface tension EDTA solutions on the bond strength of resin-based sealer to young and old root canal dentin","author":"Guzel","year":"2017","journal-title":"J. Endod."},{"issue":"10","key":"10.1016\/j.bone.2018.01.030_bb0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/iej.12713","article-title":"Clinical efficacy of EDTA ultrasonic activation in the reduction of endotoxins and cultivable bacteria","volume":"50","author":"Herrera","year":"2017","journal-title":"Int. Endod. J."},{"issue":"9","key":"10.1016\/j.bone.2018.01.030_bb0165","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jdent.2015.04.013","article-title":"Effect of EDTA conditioning on cervical restorations bonded with a self-etch adhesive: a randomized double-blind clinical trial","volume":"43","author":"Luque-Martinez","year":"2015","journal-title":"J. Dent."},{"key":"10.1016\/j.bone.2018.01.030_bb0170","article-title":"Evaluation of 17% EDTA and 10% citric acid in smear layer removal and tubular dentin sealer penetration","author":"Machado","year":"2017","journal-title":"Microsc. Res. Tech."},{"issue":"8","key":"10.1016\/j.bone.2018.01.030_bb0175","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.070504","article-title":"Noninvasive optical detection of bone mineral","volume":"22","author":"Kozloff","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2018.01.030_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132520","article-title":"A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma","volume":"10","author":"Howie","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bone.2018.01.030_bb0185","first-page":"1007","article-title":"Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells","volume":"29","author":"Abe","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.bone.2018.01.030_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00210-010-0596-4","article-title":"Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis","volume":"383","author":"Kimachi","year":"2011","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.bone.2018.01.030_bb0195","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2018.01.030_bb0200","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0003-2697(03)00288-4","article-title":"Estimation of parvalbumin Ca(2+)- and Mg(2+)-binding constants by global least-squares analysis of isothermal titration calorimetry data","volume":"319","author":"Henzl","year":"2003","journal-title":"Anal. Biochem."},{"issue":"Supplement C","key":"10.1016\/j.bone.2018.01.030_bb0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jct.2016.02.005","article-title":"Thermodynamic study of the interaction between calcium and zoledronic acid by calorimetry","volume":"97","author":"Mostefa Side Larbi","year":"2016","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.bone.2018.01.030_bb0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/TCRM.S52291","article-title":"Eliminating the need for fasting with oral administration of bisphosphonates","volume":"9","author":"Pazianas","year":"2013","journal-title":"Ther. Clin. Risk Manag."},{"issue":"4","key":"10.1016\/j.bone.2018.01.030_bb0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF02556218","article-title":"Sodium EDTA enhances intestinal absorption of two bisphosphonates","volume":"49","author":"Janner","year":"1991","journal-title":"Calcif. Tissue Int."},{"issue":"Supplement C","key":"10.1016\/j.bone.2018.01.030_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2015.11.011","article-title":"Enteric-coated tablet of risedronate sodium in combination with phytic acid, a natural chelating agent, for improved oral bioavailability","volume":"82","author":"Kim","year":"2016","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T07:37:42Z","timestamp":1569224262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":44,"alternative-id":["S8756328218300528"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.01.030","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}